Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2008

View Archived Issues

Novel cPLA2 alpha inhibitor presented at the ACS meeting

GSK-189254 shows in vivo efficacy against neuropathic, but not inflammatory, pain

AS-006 effective in vivo against inflammatory pain

AMRI initiates phase I study of tubulin inhibitor ALB-109564(a) in advanced solid tumors

Watson successfully completes pilot clinical study of Stellar's Uracyst in interstitial cystitis

FDA and Medco sign partnership to study pharmacogenetic testing of prescription drugs

Omeros and Affitech enter agreement for fully human antibodies for MASP-2

Leo Pharmaceuticals receives European approval for Xamiol for scalp psoriasis

Repros presents an update on phase II endometriosis study of Proellex

Regeneron and Bayer HealthCare announce results from a phase II study of VEGF Trap-Eye

Allergan divulges new therapeutic agents for glaucoma in a recent patent

Recent Panacea Biotec patent discloses novel antibacterial agents

Schering-Plough launches asthma inhaler Asmanex Twisthaler in the U.S.

New agents for treating neurological disorders described in recent patent literature

Transplantation of islet cells with Sertoli cells may be feasible for diabetes treatment

Further PROMISE data show efficacy of voclosporin in renal transplantation

Pfizer's PDE10A inhibitor PF-254920 may be useful for the treatment of schizophrenia

Vical's Vaxfectin adjuvant to be tested with preventive DNA vaccine against HIV

Bristol-Myers Squibb and PDL enter global alliance in multiple myeloma

Cel-Sci enters exclusive licensing agreement with Teva for cancer drug Multikine

Neurologix starts recruitment in phase II gene transfer trial in Parkinson's disease

Viralytics doses second patient group in Cavatak phase I melanoma trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...